Clinical Trial of PM60184 in Advanced Colorectal Cancer After Standard Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 16, 2018

Primary Completion Date

February 11, 2019

Study Completion Date

February 11, 2019

Conditions
Advanced Colorectal Cancer
Interventions
DRUG

PM060184

"PM060184: 9.3 mg/m2 PM060184 i.v. as a 30-minute infusion via a central or peripheral venous catheter.Dose can be rounded to the first decimal point.~PM060184 will be administered on Day 1 and Day 8 q3wk. (Three weeks=one treatment cycle)."

Trial Locations (5)

28041

ES009, Madrid

46010

ES002, Valencia

90089-9181

US017, Los Angeles

ON M5G 2M9

CA001, Toronto

08035

ES001, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

PharmaMar

INDUSTRY

NCT03427268 - Clinical Trial of PM60184 in Advanced Colorectal Cancer After Standard Treatment | Biotech Hunter | Biotech Hunter